论文部分内容阅读
目的：观察奥拉西坦治疗脑梗死恢复期轻中度认知功能障碍的临床疗效。方法选择2014年4月~2015年10月收治脑梗死患者84例，随机分为观察组与对照组，各42例。所有患者均接受常规综合治疗，观察组在常规治疗的基础上给予奥拉西坦治疗。观察两组患者临床效果及认知功能改善情况。结果经治疗后，观察组总有效率、Barthel指数、MMSE评分均明显高于对照组，差异有统计学意义（<0.05）。结论奥拉西坦能明显地改善脑梗死恢复期轻中度认知功能障碍患者的认知功能，具有良好的临床实用价值，值得推广。“,”Objective To observe the clinical curative effect of oxiracetam in the treatment of cerebral infarction convalescence patients with mild-to-moderate cognitive dysfunction. Methods Choosing 84 patients with cerebral infarction were selected from April 2014 to October 2015.They were randomly divided into the observation group and the control group with 42 cases in each.All patients received routine treatment,on the basis of conventional treatment,the observation group was treated with oxiracetam.The clinical effects and cognitive function improvement conditions of two groups were observed. Results After the treatment,the total effective rate,the Barthel index and MMSE score of the observation group were obviously higher than that of the control group,and the difference was statistically significant ( <0.05). Conclusion Oxiracetam can significantly improve the cognitive function of cerebral infarction convalescence patients with mild-to-moderate cognitive dysfunction.It is of certain clinical value and is worthy of popularization.